Want to see CNTN full AI Analyst Report?
CNTN Stock Chart & Stats
$2.23
-$0.07(-3.02%)
At close: 4:00 PM EST
$2.23
-$0.07(-3.02%)
Day’s Range― - ―
52-Week Range$1.75 - $6.89
Previous CloseN/A
VolumeN/A
Average Volume (3M)683.40K
Market Cap
$181.67M
Enterprise Value$574.32
Total Cash (Recent Filing)$37.24M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.78
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding79,681,360
10 Day Avg. Volume624,429
30 Day Avg. Volume683,405
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.24
Price to Sales (P/S)0.00
P/FCF Ratio-1.04
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Debt-Free Balance SheetZero debt and substantial equity provide financial flexibility and reduce interest and refinancing risk. This capitalization can help Canton fund strategic initiatives or absorb volatility while it works to establish a sustainable operating model.
Strategic RefocusExiting direct ownership of the clinical-stage subsidiary may narrow operational complexity and funding demands. Retained note, milestone economics, and selected assets preserve potential upside while management reallocates resources toward its revised strategy.
Governance StructureDefined committee leadership and continued board authorization strengthen oversight responsibilities and accountability. A clearer governance framework can support more disciplined capital allocation and strategic execution during the company’s business transition.
Bears Say
Severe Profitability WeaknessThe very small revenue base relative to large and expanding losses indicates that commercial scale has not yet been established. Persistent losses constrain internal reinvestment and make future progress dependent on successful execution or additional funding.
Persistent Cash BurnNegative operating and free cash flow show that the business is not self-funding its activities. Continued cash consumption can reduce the balance-sheet cushion over time and may require external capital, asset monetization, or sustained spending reductions.
Related-Party Divestiture RiskThe related-party nature of the divestiture creates ongoing governance and transaction-quality risk, even with independent committee review. Shareholders must assess whether the consideration and retained economics adequately reflect the value of the divested assets.
Canton Strategic Holdings News
CNTN FAQ
What was Canton Strategic Holdings’s price range in the past 12 months?
Canton Strategic Holdings lowest stock price was $1.75 and its highest was $6.89 in the past 12 months.
What is Canton Strategic Holdings’s market cap?
Canton Strategic Holdings’s market cap is $181.67M.
When is Canton Strategic Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Canton Strategic Holdings’s earnings last quarter?
Currently, no data Available
Is Canton Strategic Holdings overvalued?
According to Wall Street analysts Canton Strategic Holdings’s price is currently Overvalued.
Does Canton Strategic Holdings pay dividends?
Canton Strategic Holdings does not currently pay dividends.
What is Canton Strategic Holdings’s EPS estimate?
Canton Strategic Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Canton Strategic Holdings have?
Canton Strategic Holdings has 79,681,360 shares outstanding.
What happened to Canton Strategic Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Canton Strategic Holdings?
Currently, no hedge funds are holding shares in CNTN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Canton Strategic Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
CNTN Sentiment 100%
Sector Average 60%
Sector Average 60%
Hedge Fund Trend
Decreased
By 37.5K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
9999.00%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Canton Strategic Holdings
Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development. Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial. Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.
Technical Analysis
CervoMed
―
―
Champions Oncology
―
Pelthos Therapeutics
―
Artiva Biotherapeutics, Inc.
―
Ownership Overview
1.17% Insiders
0.97% Mutual Funds
10.50% Other Institutional Investors
80.48% Public Companies and
Individual Investors